## AIZ: Assurant, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.46 indicates fundamental undervaluation. Quality metrics strong (ROE 15%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-1.6% MRS), overbought RSI (77).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($233.94)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 2, Bearish: 1)

**1. Assurant (AIZ): Buy, Sell, or Hold Post Q3 Earnings?**
- Source: Finviz | 20251222T230300 | Bearish | Relevance: 100%
- Assurant (AIZ) has seen a significant stock price increase recently, outpacing the S&P 500. However, the article advises against buying AIZ due to disappointing long-term revenue growth, soft demand indicated by net premiums earned, and mediocre book value per share growth despite recent acceleration. The authors suggest better investment opportunities exist elsewhere.

**2. Assurant (AIZ): Buy, Sell, or Hold Post Q3 Earnings?**
- Source: TradingView — Track All Markets | 20251223T040742 | Somewhat-Bearish | Relevance: 100%
- This article analyzes Assurant (AIZ) following its Q3 earnings, noting its recent stock price increase and outperformance of the S&P 500. Despite this, the analysis suggests avoiding AIZ due to disappointing long-term revenue growth, soft demand indicated by net premiums earned, and only a meager increase in book value per share over the past five years, though recent BVPS growth has accelerated. The report concludes that Assurant's business quality falls short of standards, and better investment opportunities likely exist elsewhere.

**3. Assurant stock hits all-time high at 240.63 USD**
- Source: Investing.com | 20251222T154211 | Bullish | Relevance: 100%
- Assurant Inc. (AIZ) stock has reached an all-time high of $240.63, reflecting a 14.33% increase over the past year and 22.78% over six months. Despite being in overbought territory according to its RSI, analysts see potential for further upside, driven by strong Q3 2025 financial performance, a new $700 million share repurchase program, and a 10% dividend increase. The company's resilience, strategic initiatives, and favorable valuation metrics, including a P/E ratio of 14.59 and a PEG ratio of 0.82, underpin investor confidence and positive analyst revisions.

**4. 5 Stocks With High ROE to Buy as Markets Bask in Year-End Rally**
- Source: TradingView — Track All Markets | 20251222T130951 | Bullish | Relevance: 74%
- The broader equity markets have seen a mini-recovery, fueled by cooling inflation data and strong performance from blue-chip stocks, sparking optimism for potential interest rate cuts. In this environment, investors can benefit from "cash cow" stocks with high Return on Equity (ROE), which signifies efficient reinvestment of cash for higher returns. This article identifies five such stocks: TE Connectivity plc (TEL), ZTO Express (Cayman) Inc. (ZTO), Pilgrim's Pride Corporation (PPC), Assurant, Inc. (AIZ), and Host Hotels & Resorts, Inc. (HST), based on criteria like over $1 billion in cash flow, high ROE, favorable price/cash flow, high ROA, strong 5-year EPS growth, and a Zacks Rank of #1 or #2.

**5. Planned Chubb AI overhaul places 20% of jobs at risk**
- Source: Insurance Times | 20251224T072719 | Neutral | Relevance: 62%
- Chubb plans to cut approximately 20% of its global workforce, impacting 8,500 to 9,000 roles, over the next three to four years as part of a major digital transformation focused on AI and automation. This initiative aims to automate 85% of major underwriting and claims processes and generate 85% of global gross written premium digitally, positioning the insurer for an anticipated soft market. The company also projects its private investments to grow from $0.9bn to around $2bn.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Piper Sandler | $264 | $252 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Piper Sandler | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.10M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.5% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-2.0%)
- Bank Of New York Mel: 10.0% (+23.7%)
- Blackrock Inc.: 7.9% (-0.4%)
- T. Rowe Price Invest: 7.7% (-3.5%)
- State Street Corpora: 5.4% (-3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.46 suggests fair value with growth premium. Balance sheet: strong liquidity (11492000000.0x). Institutional flow bearish (9 selling vs 1 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $12.2B |
| Beta | 0.57 |
| 52W Range | $174.97 - $243.22 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.46 |
| Forward P/E | 11.6 |
| Current P/E | 12.4 |
| YoY Growth | 6.8% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 5.6% to 4.0% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.0pp (needs >4.0% for momentum thesis). MRS_5 (-0.4%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 5.1% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.29), confirming momentum. RSI overbought at 77, risk of mean reversion. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.95% (CS: 89) | Neutral |
| RSI_14 | 76.8 | Overbought |
| MACD Histogram | 1.29 | Bullish |
| vs SMA20 | 1.051x | Above |
| vs SMA50 | 1.085x | Above |
| vs SMA200 | 1.167x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $241.80
- **Stop Loss:** $233.94 (3.3% risk)
- **Target:** $257.52 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 183
- **Position Value:** $44,249.40
- **Portfolio %:** 44.25%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite supported by year-end positioning. VIX at cycle lows (13.47) and multiple sectors hitting 52-week highs indicate constructive sentiment, though breadth at 57.9% suggests selectivity remains important. Fed pause expectations and stable macro backdrop support risk assets.*

### Earnings

**Next:** 2026-02-10 (Est: $5.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.28 | $5.73 | +34.0% |
| 2025Q2 | $4.45 | $5.10 | +14.5% |
| 2025Q1 | $2.78 | $3.39 | +22.1% |
| 2024Q4 | $4.13 | $4.79 | +15.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*